Here’s a look at what’s next as F.D.A. advisers consider Moderna’s vaccine for children 6 to 17.

An independent panel of experts advising the Food and Drug Administration is scheduled to vote on Tuesday on whether to recommend to the agency that Moderna’s coronavirus vaccine be authorized for children and adolescents ages 6 to 17.

The panel’s recommendation is a key step toward authorizing the vaccine for those children, but it is not the final say. The F.D.A., the Centers for Disease Control and Prevention and state health departments all still have roles to play in deciding whether…

Read the Full Article Here nytimes


Written by Bourbiza Mohamed

A technology enthusiast and a passionate writer in the field of information technology, cyber security, and blockchain

Leave a Reply

Your email address will not be published.

Mum, 30, ‘traumatised’ after vicious dog attack leaves daughter’s face unrecognisable

Children at risk of multiple viruses because lockdown wore down their immune systems, experts warn